- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-02-0042655

Ancorra Pharma Private Limited
About Ancorra Pharma Private Limited
Data last updated:
Ancorra Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2021PTC154209.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sridhar Boddeti and Koteswara Rao Surisetty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.06 Lakh, a decline of 50% compared to the previous year. For the same year it recorded a net loss of ₹5.27 Lakh (net margin -37.5%) and EBITDA of -₹5.22 Lakh (EBITDA margin -37.1%).
Ancorra Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0042655).
Company details
Recognitions & Rankings of Ancorra Pharma
Contact details
Ancorra Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ancorra Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Ancorra Pharma Private Limited, buy the company report.
Financials of Ancorra Pharma Private Limited
FY 2025 filings availableAncorra Pharma Private Limited reported revenue of ₹14.06 Lakh (down 50% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 50% in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹5.22 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹5.27 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -37.1% | |||
| Net Profit Margin | -37.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ancorra Pharma Private Limited, buy the company report.
Board of directors of Ancorra Pharma Private Limited
Ancorra Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridhar Boddeti | Director | 19 Aug 2021 | 5 Years 2 Months | Current |
| Koteswara Rao Surisetty | Director | 19 Aug 2021 | 5 Years 2 Months | Current |
Peer comparison
Ancorra Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asarr Medisol Private Limited | ₹14.14 Lakh (FY 2018) | 330.0% | New Delhi, Delhi, India | |||
| Devraj Medical Centre Private Limited | ₹14.12 Lakh (FY 2025) | 6519.0% | Uttar Pradesh, India | |||
| Gopesh Pharmaceutical Private Limited | ₹14.09 Lakh (FY 2024) | 552.0% | Jamshedpur, Jharkhand, India | |||
| Intervein Laboratories Private Limited | ₹14.09 Lakh (FY 2025) | -84.0% | Ahmedabad, Gujarat, India | |||
| Lotus Medical Devices India Private Limited | ₹14.09 Lakh (FY 2025) | Yashoda Nagar, Uttar Pradesh, India | ||||
| Ancorra Pharma Private Limitedthis company | ₹14.06 Lakh (FY 2025) | -₹5.27 Lakh | -37.5% | -50.0% | Hyderabad, Telangana, India | |
| Schrodinger Pharmaceuticals Private Limited | ₹14.06 Lakh (FY 2024) | 12.0% | Varanasi, Uttar Pradesh, India | |||
| Ratika Hospital and Research Centre Private Limited | ₹14.05 Lakh (FY 2025) | -57.0% | Mumbai, Maharashtra, India | |||
| Nema Holistic Healthcare Private Limited | ₹14.03 Lakh (FY 2024) | 57.0% | Faridabad, Haryana, India | |||
| Brocton Laboratories Private Limited | ₹14.02 Lakh (FY 2025) | -40.0% | Ambernath, Maharashtra, India | |||
| Veinmd Private Limited | ₹14.02 Lakh (FY 2025) | 134.0% | Pune, Maharashtra, India |
To see the full peer comparison of Ancorra Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ancorra Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ancorra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ancorra Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ancorra Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Koteswara Rao Surisetty was appointed as Director on 19 Aug 2021.
Frequently asked questions
Ancorra Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 August 2021 (5+ years old) and is registered under CIN U24290TG2021PTC154209.
Ancorra Pharma has 2 current directors:
- Sridhar Boddeti - Director
- Koteswara Rao Surisetty - Director
The latest financial statements of Ancorra Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Ancorra Pharma is U24290TG2021PTC154209. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ancorra Pharma was incorporated on 19 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ancorra Pharma by revenue are Asarr Medisol Private Limited, Devraj Medical Centre Private Limited, Gopesh Pharmaceutical Private Limited, Intervein Laboratories Private Limited, Lotus Medical Devices India Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Koteswara Rao Surisetty was appointed as Director on 19 Aug 2021. Sridhar Boddeti was appointed as Director on 19 Aug 2021.
Yes, Ancorra Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0042655).
The registered office of Ancorra Pharma is at Flat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008.
Ancorra Pharma operates in the chemicals industry, in the manufacturing segment.
Ancorra Pharma can be reached at its registered office: Flat No – A220 Second Floor Block A Sy. No. 14 20 21& 22 H S Draga Shaikpet, Hyderabad, Telangana, India – 500008.

